Table 1.
Cellular receptors | Effects on dopamine cells | |
---|---|---|
Endocannabinoids | ||
2-arachidonoylglycerol (2-AG) |
CB1 (Sugiura et al., 1995), CB2 (Mechoulam et al., 1995) | Short-term synaptic depression of glutamate and GABA inputs (Melis et al., 2004a) |
Arachidonoylethanolamide (Anandamide) (a cannabinoid N-acylethanolamine) |
CB1 (Devane et al., 1992), CB2 (Mechoulam et al., 1995), TRPV1 (Zygmunt et al., 1999) | Facilitation of glutamate release and excitation (via TRPV1; Marinelli et al., 2003; Melis et al., 2008) |
Non-cannabinoid N-acylethanolamines | ||
Oleoylethanolamide |
PPARα (Fu et al., 2003) | Phosphorylation and negative modulation of β*-nAChRs (Melis et al., 2008) |
Palmitoylethanolamide |
PPARα (Lo Verme et al., 2005) | Phosphorylation and negative modulation of β*-nAChRs (Melis et al., 2008) |
N-acyl amino acids | ||
Oleoylglycine |
PPARα (Takao et al., 2015; Donvito et al., 2019) | Unknown |
See text for abbreviations.